Silk Road Medical Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 48.48 million compared to USD 40.13 million a year ago. Net loss was USD 14.14 million compared to USD 16.46 million a year ago.

Basic loss per share from continuing operations was USD 0.36 compared to USD 0.43 a year ago. Diluted loss per share from continuing operations was USD 0.36 compared to USD 0.43 a year ago.